Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Production / Operations

NuGen Medical Devices Inc. Provides Update on Health Canada License

NGMD · Price

Executive Summary

  • NuGen Medical Devices Inc. has temporarily halted sales of its devices in Canada because its Health Canada licence expired.
  • The lapse is due to a delayed certificate renewal and does not reflect any regulatory enforcement action or product safety issue.
  • A new licence application has been submitted; the company expects renewal soon and plans to resume Canadian sales once approved.

Key Details

  • The Health Canada licence for NuGen’s devices became expired because the required renewal certificate was not filed on time.
  • This expiration triggers a temporary halt of device sales in Canada; no devices are being sold in the Canadian market until the licence is reinstated.
  • The company emphasizes that the situation does not constitute a suspension, cancellation, or safety risk related to regulatory compliance or enforcement actions.
  • NuGen has already filed an application for a new licence and is maintaining active communication with Health Canada throughout the review process.
  • The company is confident that the licence will be renewed shortly, after which Canadian sales are expected to resume.
  • Operations and sales in all other regions worldwide remain unaffected by this licensing issue.
  • NuGen commits to providing further updates as more information becomes available.

Notable Quotes

  • “NuGen is confident the licence will be renewed soon, and sales will resume once the new licence becomes available.” – Liang Lin, Chief Executive Officer.
Read the original news release →

More from Nugen Medical Devices Inc.